Últimas noticias sobre Paysafe (NYSE:PSFE) Bolsa

Paysafe

Paysafe Ltd is an integrated payments platform. Its core purpose is to enable businesses and consumers to connect and transact seamlessly through capabilities in payment processing, digital wallet, and online cash solutions. The company provides payment solutions through three primary lines of business: Integrated Processing, Digital Wallet and eCash Solutions. It derives a majority of revenue from the USA followed by Germany, the UK, and all other countries.

Equities

News

Sports Betting

Small Cap

Movers

General

Gabelli ETFs Trust Gabelli Financial Services Opportunities ETF

GABF

KOMP

PSFE

Paysafe consigue la aprobación del Banco Central de Brasil para operar en el mercado regulado de apuestas deportivas y juegos online.

Paysafe obtiene licencia en Brasil y fortalece su presencia en iGaming

Earnings

Pre-Market Outlook

Markets

Trading Ideas

KYTX

RMBL

Aquí tienes cinco acciones estadounidenses que podrían llamar la atención de los inversores este martes: HD, RMBL, PSFE, KYTX y XP.

5 acciones en el foco este martes: HD, RMBL, PSFE, KYTX y XP

Paysafe Ltd

Paysafe Limited Warrants, exercisable for one Common Share of Paysafe Limited at a price of $11.50 per share

JMP Securities analyst Silvan Tuerkcan reiterates Exelixis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXEL#NASDAQ">EXEL</a>) with a Market Outperform and maintains $41 price target.

Price Target

Reiteration

Analyst Ratings

EXEL

JMP Securities Reiterates Market Outperform on Exelixis, Maintains $41 Price Target

Truist Securities analyst Michael Ciarmoli maintains Howmet Aerospace (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HWM#NYSE">HWM</a>) with a Buy and lowers the price target from $140 to $136.

Truist Securities Maintains Buy on Howmet Aerospace, Lowers Price Target to $136

Midi Health, a rising player in women&#8217;s healthcare, just closed a $63 million Series B funding round with <a href="https://www.benzinga.com/general/entertainment/25/01/42962518/meghan-markle-netflix-delay-launch-of-cooking-reality-show-after-california-fires-focus-on-the-needs-of-those-impacted">Meghan Markle</a> joining a star-powered list of <a href="https://in.benzinga.com/personal-finance/25/03/44374276/reddit-explodes-over-dividend-math-how-much-would-the-annual-dividend-be-for-a-280k-investment-investors-debate-schds-future-growth">investors</a>. The virtual healthcare startup, focused on menopause and midlife health support, also gained backing from names like comedian Amy Schumer, &#8220;White Lotus&#8221; star Connie Britton, and fashion icon Tory Burch.
The investment marks another strategic move for Markle, who has spent the past five years quietly building a portfolio focused on purpose-driven companies with female leadership at the forefront. According to<a href="https://techcrunch.com/2025/04/10/meghan-markle-has-made-another-angel-investment/"> TechCrunch</a>, other investors in this latest round include Laurene Powell Jobs' Emerson Collective and G9 Ventures. Other major figures from companies like OpenAI, Alphabet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>, GOOG)), Apple (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), Amazon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>)​, and Meta (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) have also invested in Midi Health.
Don't Miss:
<ul>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.26/share with a $1000 minimum.</a></li>
<li>Invest in the future of digital engagement: <a href="https://www.benzinga.com/money/vatom-adv">Own a piece of the $100 billion Metaverse for just $500</a>.</li>
</ul>
<h2 class="wp-block-heading">How Meghan Markle Is Quietly Redefining Women's Entrepreneurship</h2>
Midi Health offers digital clinical care for women aged 35 and over, addressing menopause symptoms and other midlife health concerns. The company aims to close the major gap in healthcare options for this demographic. About 40% of Midi's team identifies as people of color, reinforcing the company&#8217;s commitment to providing culturally responsive care.
Speaking to<a href="https://fortune.com/2025/04/08/duchess-meghan-founder-confessions-podcast-launch-as-ever-consumer-products/"> Fortune</a>, Markle encouraged women to engage more openly with finance. "Women need to see that they can build," she said. "Women don't need to be afraid to talk about finance. And I think the more financial literacy we have, the stronger we're going to be."
The Series B round saw 80 investors contributing between $10,000 and $500,000 each, with a clear focus on aligning with Midi Health's mission to empower women. In a<a href="https://www.prnewswire.com/news-releases/women-leaders-across-tech-entertainment-sports-media-and-fashion-come-together-to-invest-in-midi-health-302253241.html"> statement</a>, Midi Health highlighted that the group of investors included women leaders from industries spanning entertainment, professional sports, media, technology, and business.
Trending: With shares starting at $1.52, <a href="https://www.benzinga.com/money/how-a-10k-bet-on-health-care-originals-could-have-skyrocketed-your-portfolio">this could be your chance to invest in the future of healthcare</a>.
<h2 class="wp-block-heading">Meghan Markle's Investment Map</h2>
Markle's growing angel investment portfolio now spans over ten companies, with a strong emphasis on brands led by women and those prioritizing wellness, health, and education. Previous investments include wellness-focused companies like Clevr, a beverage brand she's supported since 2020, and Highbrow Hippie.
Midi Health's service model is structured for both insured and self-paying patients. The startup&#8217;s virtual care system is designed to make expert menopause support more accessible to women across the U.S., offering personalized treatment plans through a team of specialized clinicians.
Markle's partnership with Midi Health comes at a time when women's health startups are gaining more attention from both investors and the public. According to a Silicon Valley Bank<a href="https://www.svb.com/trends-insights/reports/womens-health-report/"> report</a>, women's health investment hit $2.6 billion last year, surpassing 2023's total by nearly $1 billion. The startup's strategic growth aligns with broader market trends pushing for better healthcare solutions tailored to women's specific needs.
See Also: Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">invest pre-IPO from $0.60 per share now</a>.
<h2 class="wp-block-heading">Building A New Empire Across The Atlantic</h2>
Since relocating to the U.S. and stepping away from royal duties, Markle and her husband, Prince Harry, have been steadily building a business presence, investing significant sums into various American startups. Their portfolio reflects a vision of supporting companies that drive social impact and champion underrepresented communities.
Midi Health&#8217;s latest funding round secures the company&#8217;s future growth and also signals a larger shift in the healthcare landscape. With names like Markle leading the way, the conversation around women&#8217;s midlife health is finally taking center stage.
Read Next:
<ul>
<li>BlackRock is calling 2025 the year of alternative assets. <a href="https://www.benzinga.com/money/masterworks">One firm from NYC has quietly built a group of 60,000+ investors who have all joined in on an alt asset class previously exclusive to billionaires like Bezos and Gates.</a></li>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!</a></li>
</ul>

AAPL

AMZN

GOOGL

Meghan Markle Invests In $63M Midi Health Round As Top Women From OpenAI, Google, Meta, And Hollywood Rally Behind Menopause Care

Truist Securities analyst Michael Ciarmoli maintains Hexcel (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HXL#NYSE">HXL</a>) with a Buy and lowers the price target from $80 to $73.

Truist Securities Maintains Buy on Hexcel, Lowers Price Target to $73

Correction : Canaccord Genuity analyst Kyle Mikson maintains Repligen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGEN#NASDAQ">RGEN</a>) with a Hold and lowers the price target from $170 to $150. (Ticker changed)

RGEN

Correction : Canaccord Genuity Maintains Hold on Repligen, Lowers Price Target to $150 (Ticker changed)

Westinghouse Air Brake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WAB#NYSE">WAB</a>) has outperformed the market over the past 5 years by 13.69% on an annualized basis producing an average annual return of 27.79%. Currently, Westinghouse Air Brake has a market capitalization of $28.90 billion. 
Buying $1000 In WAB: If an investor had bought $1000 of WAB stock 5 years ago, it would be worth $3,485.80 today based on a price of $169.18 for WAB at the time of writing.
<h3>Westinghouse Air Brake's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1744899313_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In This Stock 5 Years Ago Would Be Worth This Much Today

Truist Securities analyst Michael Ciarmoli maintains Heico (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HEI#NYSE">HEI</a>) with a Buy and lowers the price target from $294 to $277.

Truist Securities Maintains Buy on Heico, Lowers Price Target to $277

JMP Securities analyst Patrick Walravens reiterates Docusign (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOCU#NASDAQ">DOCU</a>) with a Market Outperform and maintains $124 price target.

DOCU

JMP Securities Reiterates Market Outperform on Docusign, Maintains $124 Price Target

Truist Securities analyst Michael Ciarmoli maintains Ducommun (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DCO#NYSE">DCO</a>) with a Buy and lowers the price target from $82 to $70.

Truist Securities Maintains Buy on Ducommun, Lowers Price Target to $70

Truist Securities analyst Neal Dingmann maintains Diamondback Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FANG#NASDAQ">FANG</a>) with a Buy and raises the price target from $238 to $242.

FANG

Truist Securities Maintains Buy on Diamondback Energy, Raises Price Target to $242

ST. PETERSBURG, Fla., April 17, 2025 (GLOBE NEWSWIRE) -- Raymond James continues its investment in artificial intelligence as a crucial component of service excellence with the launch of its proprietary AI Search technology. Powered by generative artificial intelligence, AI Search enables both financial advisors and associates to ask intuitive, natural language questions to the firm's vast internal knowledge base and receive precise, tailored information in return, according to Stuart Feld, <a href="https://www.globenewswire.com/Tracker?data=eb9luQHHnAmcepwIOg1Cy6Lo4P0GR78KVKvFlqTkmPoOk5qj0Rob9GfvFGXO0g-gzJGnJrz9U-VjlLTdgVbIA1Su-SSpxXYEFVsxLFPnw2wLfFH1At5Fcgkl-KV-pjOpxOy8EE_m0w5un1ry8is_nV60oWQ-mqRiLZdZS3Y_7JdFXbBrDIm5KpYzep3xZlC2UuFRf2BZ12Ba72JOrt9oAyn8HHSPf9PPLaziq1uJP1yhok7MlmWUs-7zk40dsI4VWIZn58YY7jwfP92LcOVEQHjvrlRfHjKbCo33kTZYv18=">newly appointed</a> chief artificial intelligence officer.

Raymond James Continues Investment In AI With Launch Of Its Proprietary AI Search Technology

Truist Securities analyst Michael Ciarmoli maintains Curtiss-Wright (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CW#NYSE">CW</a>) with a Hold and lowers the price target from $357 to $338.

Truist Securities Maintains Hold on Curtiss-Wright, Lowers Price Target to $338

Truist Securities analyst Brian Foran maintains Citizens Financial Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CFG#NYSE">CFG</a>) with a Hold and lowers the price target from $51 to $43.

Truist Securities Maintains Hold on Citizens Financial Group, Lowers Price Target to $43

Truist Securities analyst Michael Ciarmoli maintains Astronics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATRO#NASDAQ">ATRO</a>) with a Hold and lowers the price target from $23 to $21.

ATRO

Truist Securities Maintains Hold on Astronics, Lowers Price Target to $21

Trading Halt: Halt status updated at 10:10:00 AM ET: Quotation Resumption: IPO Security - Released for Quotation

Truist Securities analyst Jordan Levy reiterates Array Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARRY#NASDAQ">ARRY</a>) with a Buy and lowers the price target from $8 to $7.

ARRY

Truist Securities Reiterates Buy on Array Technologies, Lowers Price Target to $7

Keybanc analyst Eric Heath maintains Winnebago Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WGO#NYSE">WGO</a>) with a Overweight and lowers the price target from $47 to $40.

Keybanc Maintains Overweight on Winnebago Industries, Lowers Price Target to $40

Truist Securities analyst Youssef Squali maintains Alphabet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) with a Buy and lowers the price target from $220 to $200.

GOOG

Truist Securities Maintains Buy on Alphabet, Lowers Price Target to $200

Keybanc analyst Jackson Ader maintains Thor Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THO#NYSE">THO</a>) with a Underweight and lowers the price target from $65 to $60.

Keybanc Maintains Underweight on Thor Industries, Lowers Price Target to $60

Truist Securities analyst Michael Ciarmoli maintains Albany International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIN#NYSE">AIN</a>) with a Buy and lowers the price target from $88 to $80.

Comments

Paysafe

Noticias

Últimas noticias sobre Paysafe (NYSE:PSFE) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL